Zachary S Lorsch1, Alberto Ambesi-Impiombato2, Rebecca Zenowich2, Irene Morganstern2, Emer Leahy2, Mukesh Bansal2, Eric J Nestler3, Taleen Hanania4. 1. Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York. 2. PsychoGenics Inc., Paramus, New Jersey. 3. Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: eric.nestler@mssm.edu. 4. PsychoGenics Inc., Paramus, New Jersey. Electronic address: taleen.hanania@psychogenics.com.
Abstract
BACKGROUND: The study of depression in humans depends on animal models that attempt to mimic specific features of the human syndrome. Most studies focus on one or a few behavioral domains, with time and practical considerations prohibiting a comprehensive evaluation. Although machine learning has enabled unbiased analysis of behavior in animals, this has not yet been applied to animal models of psychiatric disease. METHODS: We performed chronic social defeat stress (CSDS) in mice and evaluated behavior with PsychoGenics' SmartCube, a high-throughput unbiased automated phenotyping platform that collects >2000 behavioral features based on machine learning. We evaluated group differences at several times post-CSDS and after administration of the antidepressant medication imipramine. RESULTS: SmartCube analysis after CSDS successfully separated control and defeated-susceptible mice, and defeated-resilient mice more resembled control mice. We observed a potentiation of CSDS effects over time. Treatment of susceptible mice with imipramine induced a 40.2% recovery of the defeated-susceptible phenotype as assessed by SmartCube. CONCLUSIONS: High-throughput analysis can simultaneously evaluate multiple behavioral alterations in an animal model for the study of depression, which provides a more unbiased and holistic approach to evaluating group differences after CSDS and perhaps can be applied to other mouse models of psychiatric disease.
BACKGROUND: The study of depression in humans depends on animal models that attempt to mimic specific features of the human syndrome. Most studies focus on one or a few behavioral domains, with time and practical considerations prohibiting a comprehensive evaluation. Although machine learning has enabled unbiased analysis of behavior in animals, this has not yet been applied to animal models of psychiatric disease. METHODS: We performed chronic social defeat stress (CSDS) in mice and evaluated behavior with PsychoGenics' SmartCube, a high-throughput unbiased automated phenotyping platform that collects >2000 behavioral features based on machine learning. We evaluated group differences at several times post-CSDS and after administration of the antidepressant medication imipramine. RESULTS: SmartCube analysis after CSDS successfully separated control and defeated-susceptible mice, and defeated-resilient mice more resembled control mice. We observed a potentiation of CSDS effects over time. Treatment of susceptible mice with imipramine induced a 40.2% recovery of the defeated-susceptible phenotype as assessed by SmartCube. CONCLUSIONS: High-throughput analysis can simultaneously evaluate multiple behavioral alterations in an animal model for the study of depression, which provides a more unbiased and holistic approach to evaluating group differences after CSDS and perhaps can be applied to other mouse models of psychiatric disease.
Authors: Adem Can; David T Dao; Chantelle E Terrillion; Sean C Piantadosi; Shambhu Bhat; Todd D Gould Journal: J Vis Exp Date: 2012-01-28 Impact factor: 1.355
Authors: Tracy L Bale; Ted Abel; Huda Akil; William A Carlezon; Bita Moghaddam; Eric J Nestler; Kerry J Ressler; Scott M Thompson Journal: Neuropsychopharmacology Date: 2019-05-02 Impact factor: 7.853
Authors: Joseph R Scarpa; Mena Fatma; Yong-Hwee E Loh; Said Romaric Traore; Theo Stefan; Ting Huei Chen; Eric J Nestler; Benoit Labonté Journal: Biol Psychiatry Date: 2020-01-22 Impact factor: 13.382
Authors: Maha Elsayed; Mounira Banasr; Vanja Duric; Neil M Fournier; Pawel Licznerski; Ronald S Duman Journal: Biol Psychiatry Date: 2012-04-17 Impact factor: 13.382
Authors: Brandon L Warren; Vincent F Vialou; Sergio D Iñiguez; Lyonna F Alcantara; Katherine N Wright; Jiang Feng; Pamela J Kennedy; Quincey Laplant; Li Shen; Eric J Nestler; Carlos A Bolaños-Guzmán Journal: Biol Psychiatry Date: 2012-07-12 Impact factor: 13.382
Authors: Solal Bloch; Katherine M Holleran; Thomas L Kash; Elena M Vazey; Jennifer A Rinker; Christina L Lebonville; Krysten O'Hara; Marcelo F Lopez; Sara R Jones; Kathleen A Grant; Howard C Becker; Patrick J Mulholland Journal: Alcohol Date: 2022-02-15 Impact factor: 2.405
Authors: William McCarthy; Shama N Huq; Kristen Allen; Lindsay Scally; Avelina Petri; Madeline Wujek; Benjamin D Sachs Journal: Front Behav Neurosci Date: 2022-09-20 Impact factor: 3.617